Stem Cell Research (Jan 2019)

Generation of two spinal muscular atrophy (SMA) type I patient-derived induced pluripotent stem cell (iPSC) lines and two SMA type II patient-derived iPSC lines

  • K.R. Valetdinova,
  • M.A. Maretina,
  • M.L. Kuranova,
  • E.V. Grigor'eva,
  • Y.M. Minina,
  • E.A. Kizilova,
  • A.V. Kiselev,
  • S.P. Medvedev,
  • V.S. Baranov,
  • S.M. Zakian

Journal volume & issue
Vol. 34

Abstract

Read online

Spinal muscular atrophy (SMA) is a neuromuscular disease caused by deletion or mutation in SMN1 gene. SMA human induced pluripotent stem cells (iPSCs) represent a useful and valid model for the study of the disorder, as they provide in vitro the target cells. We generated iPSCs from a SMA type I patient and SMA type II patient by using non-integrating episomal plasmid vectors. The resulting iPSCs are episomal-free, express pluripotency markers, display a normal karyotype, retain the mutation (homozygous deletion of SMN1) and are able to differentiate into the three germ layers.